FindTrial
Sign In

Studying of Peripheral Neuropathy, Fatigue and Sarcopenia in Children with Acute Lymphoblastic Leukemia (ALL) and Lymphoma

Evaluation of Chemotherapy-Induced Peripheral Neuropathy, Sarcopenia, and Fatigue in Children with Acute Lymphoblastic Leukemia and Lymphoma in Maintenance Phase.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045847
Enrollment
50
Registered
2022-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]

Interventions

None listed

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children of 5-18 years during maintenance phase with Acute Lymphoblastic Leukemia and Lymphoma receiving chemotherapy. The ECOG score <2 will be included.

Exclusion criteria

Exclusion criteria: 1. Participants with severe orthopedic and neurological dysfunctions that may limit them from participating in the study. 2. Participants with Metastasis.

Design outcomes

Primary

MeasureTime frame
Severity of side effects of chemotherapyTimepoint: 3-Time points, i.e., at start of maintenance phase, at 3 months and and at 6 months of maintenance phase—

Secondary

MeasureTime frame
Help in evaluating the overall quality of life of children through physical performance, fatigue and sarcopenia assessment.Timepoint: 3-Time points, i.e., at start of maintenance phase, at 3 months and and at 6 months of maintenance phase—

Countries

India

Contacts

Public ContactNishtha Manoj Singhal

Kasturba Medical College, Mangalore

stephen.samuel@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026